- Home
- BIAF vs PAVM Comparison
BIAF vs PAVM Comparison
Compare BIAF & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- PAVM
- Stock Information
- Founded
- BIAF 2014
- PAVM 2014
- Country
- BIAF United States
- PAVM United States
- Employees
- BIAF N/A
- PAVM N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PAVM Medical/Dental Instruments
- Sector
- BIAF Health Care
- PAVM Health Care
- Exchange
- BIAF Nasdaq
- PAVM Nasdaq
- Market Cap
- BIAF 7.1M
- PAVM 8.0M
- IPO Year
- BIAF 2022
- PAVM 2016
- Fundamental
- Price
- BIAF $0.24
- PAVM $0.45
- Analyst Decision
- BIAF Hold
- PAVM Strong Buy
- Analyst Count
- BIAF 1
- PAVM 1
- Target Price
- BIAF N/A
- PAVM $19.00
- AVG Volume (30 Days)
- BIAF 468.1K
- PAVM 376.9K
- Earning Date
- BIAF 08-14-2025
- PAVM 08-14-2025
- Dividend Yield
- BIAF N/A
- PAVM N/A
- EPS Growth
- BIAF N/A
- PAVM N/A
- EPS
- BIAF N/A
- PAVM 0.83
- Revenue
- BIAF $7,681,059.00
- PAVM $1,020,000.00
- Revenue This Year
- BIAF N/A
- PAVM N/A
- Revenue Next Year
- BIAF $20.00
- PAVM $455.63
- P/E Ratio
- BIAF N/A
- PAVM $0.54
- Revenue Growth
- BIAF 4.99
- PAVM N/A
- 52 Week Low
- BIAF $0.16
- PAVM $0.30
- 52 Week High
- BIAF $2.26
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- BIAF 39.54
- PAVM 43.12
- Support Level
- BIAF $0.24
- PAVM $0.42
- Resistance Level
- BIAF $0.26
- PAVM $0.49
- Average True Range (ATR)
- BIAF 0.02
- PAVM 0.04
- MACD
- BIAF 0.00
- PAVM 0.00
- Stochastic Oscillator
- BIAF 17.02
- PAVM 30.87
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.